Cargando…
Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184852/ https://www.ncbi.nlm.nih.gov/pubmed/37197060 http://dx.doi.org/10.2147/DMSO.S404352 |
_version_ | 1785042224002629632 |
---|---|
author | Yang, Wensu Xia, Zhaoxin Zhu, Yi Tang, Hao Xu, Huaming Hu, Xinyi Lin, Chunhui Jiang, Tong He, Pei Shen, Jilu |
author_facet | Yang, Wensu Xia, Zhaoxin Zhu, Yi Tang, Hao Xu, Huaming Hu, Xinyi Lin, Chunhui Jiang, Tong He, Pei Shen, Jilu |
author_sort | Yang, Wensu |
collection | PubMed |
description | BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying mechanism remains unclear. Therefore, in the present study, we aimed to investigate the role of FMT in T2D and its underlying mechanisms. METHODS: To induce T2D, mice were fed a high-fat diet and injected with low-dose streptozotocin (STZ) for four weeks. The mice were then randomly divided into four groups: control group (n = 7), T2D group (n = 7), metformin (MET)-treated group (n = 7), and FMT group (n = 7). The MET group was orally administered 0.2 g/kg MET, the FMT group was orally administered 0.3 mL of bacterial solution, and the other two groups were orally administered the same volume of saline for four weeks. Serum and fecal samples were collected for non-targeted metabolomics, biochemical indicators, and 16S rRNA sequencing, respectively. RESULTS: Our results demonstrated that FMT had a curative effect on T2D by ameliorating hyperlipidemia and hyperglycemia. Using 16S rRNA sequencing and serum untargeted metabolomic analysis, we found that FMT could restore the disorders of gastrointestinal microbiota in T2D mice. Moreover, corticosterone, progesterone, L-urobilin, and other molecules were identified as biomarkers after FMT treatment. Our bioinformatics analysis suggested that steroid hormone biosynthesis, arginine, proline metabolism, and unsaturated fatty acid biosynthesis could be potential regulatory mechanisms of FMT. CONCLUSION: In summary, our study provides comprehensive evidence for the role of FMT in the treatment of T2D. FMT has the potential to become a promising strategy for the treatment of metabolic disorders, T2D, and diabetes-related complications. |
format | Online Article Text |
id | pubmed-10184852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-101848522023-05-16 Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D Yang, Wensu Xia, Zhaoxin Zhu, Yi Tang, Hao Xu, Huaming Hu, Xinyi Lin, Chunhui Jiang, Tong He, Pei Shen, Jilu Diabetes Metab Syndr Obes Original Research BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying mechanism remains unclear. Therefore, in the present study, we aimed to investigate the role of FMT in T2D and its underlying mechanisms. METHODS: To induce T2D, mice were fed a high-fat diet and injected with low-dose streptozotocin (STZ) for four weeks. The mice were then randomly divided into four groups: control group (n = 7), T2D group (n = 7), metformin (MET)-treated group (n = 7), and FMT group (n = 7). The MET group was orally administered 0.2 g/kg MET, the FMT group was orally administered 0.3 mL of bacterial solution, and the other two groups were orally administered the same volume of saline for four weeks. Serum and fecal samples were collected for non-targeted metabolomics, biochemical indicators, and 16S rRNA sequencing, respectively. RESULTS: Our results demonstrated that FMT had a curative effect on T2D by ameliorating hyperlipidemia and hyperglycemia. Using 16S rRNA sequencing and serum untargeted metabolomic analysis, we found that FMT could restore the disorders of gastrointestinal microbiota in T2D mice. Moreover, corticosterone, progesterone, L-urobilin, and other molecules were identified as biomarkers after FMT treatment. Our bioinformatics analysis suggested that steroid hormone biosynthesis, arginine, proline metabolism, and unsaturated fatty acid biosynthesis could be potential regulatory mechanisms of FMT. CONCLUSION: In summary, our study provides comprehensive evidence for the role of FMT in the treatment of T2D. FMT has the potential to become a promising strategy for the treatment of metabolic disorders, T2D, and diabetes-related complications. Dove 2023-05-11 /pmc/articles/PMC10184852/ /pubmed/37197060 http://dx.doi.org/10.2147/DMSO.S404352 Text en © 2023 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yang, Wensu Xia, Zhaoxin Zhu, Yi Tang, Hao Xu, Huaming Hu, Xinyi Lin, Chunhui Jiang, Tong He, Pei Shen, Jilu Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title | Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title_full | Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title_fullStr | Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title_full_unstemmed | Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title_short | Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D |
title_sort | comprehensive study of untargeted metabolomics and 16s rrna reveals the mechanism of fecal microbiota transplantation in improving a mouse model of t2d |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184852/ https://www.ncbi.nlm.nih.gov/pubmed/37197060 http://dx.doi.org/10.2147/DMSO.S404352 |
work_keys_str_mv | AT yangwensu comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT xiazhaoxin comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT zhuyi comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT tanghao comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT xuhuaming comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT huxinyi comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT linchunhui comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT jiangtong comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT hepei comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d AT shenjilu comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d |